Gelatin-encapsulated controlled-release composition

Claim 2

A pharmaceutical unit dosage form comprising a gelatin shell enclosing a gelled polymeric matrix, characterized by having been prepared by the process consisting essentially of: (a) forming a liquid fill comprising an aqueous solution or dispersion of a polysaccharide gum and pharmaceutically-active compound; (b) encapsulating said liquid fill in a gelatin shell wherein the gelatin shell comprises gelatin, an effective amount of a plasticizer, water and an amount of cationic gelling agent effective to gel said liquid fill; and (c) gelling said liquid fill with the cationic gelling agent.

Claim 3

The pharmaceutical unit dosage form of claim 1 wherein the polysaccharide gum is selected from the group consisting of alginate, kappa-carrageenan and pectin.

Claim 4

The pharmaceutical unit dosage form of claim 1 wherein the gelling agent comprises a metal cation or an ammonium ion.

Claim 5

The pharmaceutical unit dosage form of claim 3 wherein the gelling agent comprises a chloride salt.

Claim 6

The pharmaceutical unit dosage form of claim 1 wherein the aqueous solution or dispersion further comprises propylene carbonate or a liquid polyethylene glycol.

Claim 7

A pharmaceutical unit dosage form comprising a gelatin shell including an effective amount of a gelling agent comprising metal cations or ammonium ions, wherein said shell encloses a water-soluble or water-dispersable gelled polymeric matrix and a pharmaceutically-active compound dispersed throughout said matrix, wherein said matrix is formed in situ by the gellation of a liquid fill comprising an aqueous solution or dispersion of the pharmaceutically-active compound and a polysaccharide gum, by means of said gelling agent, following the encapsulation of the liquid fill, so that the phramaceutically-active compound is released from said gelled polymeric matrix over a prolonged period when said capsule is ruptured in an aqueous medium.

Claim 8

A pharmaceutical unit dosage form comprising a gelatin shell including an effective amount of a gelling agent comprising metal cations or ammonium ions, wherein said shell encloses a water-soluble or water-dispersable gelled polymeric matrix and a pharmaceutically-active compound dispersed throughout said matrix, wherein said matrix is formed in situ by the gellation of a liquid fill comprising an aqueous solution or dispersion of the pharmaceutically-active compound and a polysaccharide gum, by means of said gelling agent, following the encapsulation of the liquid fill, so that the phramaceutically-active compound is released from said gelled polymeric matrix over a prolonged period when said capsule is ruptured in an aqueous medium.

Claim 9

The pharmaceutical unit dosage form of claim 6 wherein said gelatin capsule comprises gelatin, an effective amount of a plasticizer, and water.

Claim 10

The pharmaceutical unit dosage form of claim 6 wherein said gelatin capsule is a two-piece, hard gelatin capsule.

Claim 11

The pharmaceutical unit dosage form of claim 6 wherein said polysaccharide gum comprises a vegetable gum.

Claim 12

The pharmaceutical unit dosage form of claim 9 wherein the vegetable gum is selected from the group consisting of alginate, kappa-carrageenan, pectin and mixtures thereof.

Claim 13

The pharmaceutical unit dosage form of claim 9 wherein the cationic gelling agent comprises alkali metal cations or alkaline earth metal cations.

Claim 14

The pharmaceutical unit dosage form of claim 6 wherein the aqueous solution or dispersion comprises a liquid polyethylene glycol.

Claim 15

The pharmaceutical unit dosage form of claim 12 wherein the aqueous solution or dispersion comprises glycerin, propylene glycol or mixtures thereof.

Claim 16

The pharmaceutical unit dosage form of claim 12 wherein the aqueous solution comprises a polysorbate or a triglyceride dispersing agent.

Claim 17

The pharmaceutical unit dosage form of claim 12 wherein the aqueous solution or dispersion comprises a cellulosic bulking agent.

Claim 18

A pharmaceutical unit dosage form comprising a soft gelatin shell including an effective amount of a cationic gelling agent comprising metal cations or ammonium ions, wherein said shell encloses a water-soluble or water-dispersable gelled polymeric matrix and an effective amount of a pharmaceutically-active compound dispersed throughout said matrix, wherein said matrix is formed in situ by the gellation of a liquid fill composition comprising about 0.1-20% of a vegetable gum selected from the group consisting of alginate, kappa-carrageenan, pectin and mixtures thereof; the pharmaceutically-active compound, about 5-60% of a liquid polyethylene glycol, and about 5-75% water; wherein said gellation is accomplished with the cationic gelling agent, following the encapsulation of the liquid fill, so that the pharmaceutically-active compound is released from said gelled polymeric matrix over a prolonged period when said capsule is ruptured in a physiological medium.

Claim 19

A pharmaceutical unit dosage form comprising a soft gelatin shell including an effective amount of a cationic gelling agent comprising metal cations or ammonium ions, wherein said shell encloses a water-soluble or water-dispersable gelled polymeric matrix and an effective amount of a pharmaceutically-active compound dispersed throughout said matrix, wherein said matrix is formed in situ by the gellation of a liquid fill composition comprising about 0.1-20% of a vegetable gum selected from the group consisting of alginate, kappa-carrageenan, pectin and mixtures thereof; the pharmaceutically-active compound, about 5-60% of a liquid polyethylene glycol, and about 5-75% water; wherein said gellation is accomplished with the cationic gelling agent, following the encapsulation of the liquid fill, so that the pharmaceutically-active compound is released from said gelled polymeric matrix over a prolonged period when said capsule is ruptured in a physiological medium.

Claim 20

The pharmaceutical unit dosage form of claim 16 wherein the cationic gelling agent comprises potassium chloride, calcium chloride or mixtures thereof.

Claim 21

The pharmaceutical unit dosage form of claim 16 wherein the liquid fill composition further comprises about 1-15% of a C 2 -C 4 polyol, a lower (alkanol) or mixtures thereof.

Claim 22

The pharmaceutical unit dosage form of claim 16 wherein the liquid fill further comprises about 0.1-90% of a bulking agent.